Newsroom

For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Emily Wight, Communications Manager.

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Dr. Jacqueline Quandt at the Djavad Mowafaghian Centre for Brain Health.
Intranasal protein limits disability in models of MS Aug 27, 2019

Can a protein applied to the inside of the nose reduce inflammation in the central nervous system?

New research from Dr. Jacqueline Quandt’s laboratory suggests that intranasal administration of E-selectin, a type of protein that is expressed by blood vessel cells in an attempt to recruit immune cells, can bolster an immunosuppressive response in the body and calm inflammation in the brain in models of multiple sclerosis (MS).

+
Dr. Weihong Song in his lab.
Newly discovered gene function may reduce cell death in Alzheimer disease and Down syndrome Aug 27, 2019

The discovery of a new role for a gene associated with neurodevelopmental and neurodegenerative disorders finds possible prenatal origin for Alzheimer disease (AD), according to a study published today in the journal Molecular Psychiatry.

+
A group of older adults in group physical therapy.
FAME for NEUROFITNESS program at UBC clinic merges physical therapy and research Aug 23, 2019

A new UBC Physical Therapy & Research Clinic for people with neurological conditions has opened across the street from the Djavad Mowafaghian Centre for Brain Health, offering people living with movement disorders, stroke, and multiple sclerosis (MS) access to a group exercise program tailored to their specific needs.

+
Tariq Aziz, Laura Harvey, Dr. Rob Carruthers, and Jamie McDowell.
Member news: August 2019 Aug 21, 2019

Pictured: Tariq Aziz, Laura Harvey, Dr. Rob Carruthers, and Jamie McDowell join colleagues with the UBC MS & NMO Program in support of Burgers to Beat MS on August 22. Image credit: Michelle Eisner.

Congratulations

Dr. Wolfram Tetzlaff was reappointed as ICORD Director.

+
Dr. Nick Weilinger.
Member news: July 2019 Jul 30, 2019

Pictured: Dr. Nick Weilinger (PI: Dr. Brian MacVicar), who won an award for best basic science poster at the Department of Psychiatry's annual Research Day in June. Image credit: Paul Joseph/UBC.

+
Dr. Weihong Song and Dr. Yun Zhang.
Protein meant to protect cells may also serve as a biomarker for Alzheimer disease Jul 23, 2019

Pictured: Dr. Weihong Song (left) with Dr. Yun Zhang (right), co-first author on the paper described below. Image credit: Paul Joseph/UBC.

+
Older man sleeping peacefully.
Resetting circadian rhythms can improve sleep quality in people at risk for dementia Jul 15, 2019

Can improving sleep quality protect older adults from cognitive decline? New research presented today at the Alzheimer’s Association International Conference (AAIC) suggests that improving circadian regulation by “resetting” an individual’s biological clock can improve sleep quality in older adults with mild cognitive impairment.

+
Dr. Christoph Birkl with Dr. Alex Rauscher.
CIHR funds innovative brain research projects at UBC Jul 13, 2019

Pictured: Dr. Christoph Birkl (left) celebrates with supervisor and Principal Investigator Dr. Alex Rauscher (right) from Innsbruck, Austria. Image source: Dr. Alex Rauscher.

Congratulations to our members who recently received Project Grants from the Canadian Insitutes of Health Research (CIHR). CIHR Project Grants support research projects with a defined endpoint, allowing researchers to pursue innovative, high-risk research questions with potential to improve health outcomes in Canada.

+
Dr. Sriram Subramaniam at the DMCBH.
UBC scientists capture images of gene-editing enzymes in action Jul 8, 2019

For the first time, scientists have captured high-resolution, three-dimensional images of an enzyme in the process of precisely cutting DNA strands.

The images—captured using a technique called cryogenic electron microscopy, or cryo-EM—reveal new information about how a gene-editing tool called CRISPR-Cas9 works, which may help researchers develop versions of it that operate more efficiently and precisely to alter targeted genes.

+
Dr. Annie Vogel Ciernia.
Dr. Annie Vogel Ciernia’s lab to look at immunological underpinnings of neurodevelopmental disorders Jul 2, 2019

Dr. Annie Vogel Ciernia opened her lab at the Djavad Mowafaghian Centre for Brain Health today; she joins the University of British Columbia as an Assistant Professor in the Department of Biochemistry & Molecular Biology, having completed a postdoctoral fellowship at the University of California–Davis (UC Davis). Dr. Ciernia’s research program will focus on how genes control development in the brain, and the mechanisms by which disruptions in gene regulation can negatively impact brain function.

+

Pages